5-Amino-1MQ

NNMT inhibitor (small molecule, not a peptide) studied for fat loss and muscle anabolism via methylation balance.

This is a small molecule, not a peptide. It blocks an enzyme called NNMT that runs overactive in fat tissue; when NNMT is high, fat cells store energy lazily and waste the cell's methylation currency. Inhibiting it pushes fat cells to burn more energy and frees up resources for muscle — so in research it shows fat loss alongside a mild anabolic effect. Taken orally, it's an experimental "metabolic flexibility" tool with limited human data so far.

Dose
50–150 mg oral daily.
Reconstitute
Oral (capsule). Injectable form: 50 mg + 1 mL bac water.
Schedule
30–60 day cycles.
Half-life
Hours.
Timing
AM with food.
Risks
Limited human data. Oral bioavailability variable.

within Metabolic & Mitochondrial